2016 Philip S. Portoghese Medicinal Chemistry Lectureship: Designing Bivalent or Bitopic Molecules for G-Protein Coupled Receptors. The Whole Is Greater Than the Sum of Its Parts | Journal of Medicinal Chemistry
![Biomaterials for Modulating Lymphatic Function in Immunoengineering | ACS Pharmacology & Translational Science Biomaterials for Modulating Lymphatic Function in Immunoengineering | ACS Pharmacology & Translational Science](https://pubs.acs.org/cms/10.1021/acsptsci.9b00047/asset/images/large/pt9b00047_0006.jpeg)
Biomaterials for Modulating Lymphatic Function in Immunoengineering | ACS Pharmacology & Translational Science
![PDF) Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: A statement from the ESA-ESICM joint taskforce on perioperative outcome PDF) Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: A statement from the ESA-ESICM joint taskforce on perioperative outcome](https://i1.rgstatic.net/publication/264201420_Standards_for_definitions_and_use_of_outcome_measures_for_clinical_effectiveness_research_in_perioperative_medicine_European_Perioperative_Clinical_Outcome_EPCO_definitions_A_statement_from_the_ESA-ES/links/56a750bb08ae860e025553aa/largepreview.png)
PDF) Standards for definitions and use of outcome measures for clinical effectiveness research in perioperative medicine: European Perioperative Clinical Outcome (EPCO) definitions: A statement from the ESA-ESICM joint taskforce on perioperative outcome
![IJMS | Free Full-Text | Combined Gemcitabine and Immune-Checkpoint Inhibition Conquers Anti-PD-L1 Resistance in Low-Immunogenic Mismatch Repair-Deficient Tumors IJMS | Free Full-Text | Combined Gemcitabine and Immune-Checkpoint Inhibition Conquers Anti-PD-L1 Resistance in Low-Immunogenic Mismatch Repair-Deficient Tumors](https://pub.mdpi-res.com/ijms/ijms-22-05990/article_deploy/html/images/ijms-22-05990-ag.png?1622601022)
IJMS | Free Full-Text | Combined Gemcitabine and Immune-Checkpoint Inhibition Conquers Anti-PD-L1 Resistance in Low-Immunogenic Mismatch Repair-Deficient Tumors
![OLTL & GH Alum Bree Williamson Stars in Lifetime Movie OLTL & GH Alum Bree Williamson Stars in Lifetime Movie](https://3.bp.blogspot.com/-Dq_5qHpCjoQ/WJ0KAhRanWI/AAAAAAAAD6c/SxwrYdz7-2Qc46PLUfoMh7zy_-Oak5-sgCLcB/s1600/MV5BMTU4NDI5MTEzNl5BMl5BanBnXkFtZTgwMDE2MDM5ODE%2540._V1_SY1000_SX1500_AL_.jpg)